05 Sep SYSF Survey! Melanoma Treatments for Adjuvant Patients
Save Your Skin has the opportunity to submit patient feedback to the pCODR process for the two treatments coming to the Adjuvant setting for Melanoma patients in Canada. To learn more about the drug approval process and our involvement as a patient representation group, please visit our page: “Let’s Chat: Patient Submissions and Discussion”
We believe the ability of stage I, II, and II melanoma patients to receive innovative treatments is key to survival, and to the reduction of progression to stage IV disease.
To inform our upcoming submission, we have created a short survey and request that any and all patients touched by melanoma complete the survey to have their voices heard. This survey is open globally, to all stage melanoma patients at any point in their journey; but we request that IF you are a metastatic patient taking the survey, but were diagnosed at stage 1, 2 or 3 could you please take some time to remember back to those days and fill in what you can in the survey pertaining to those times. Were you offered a treatment, were you advised to “wait and watch” and what were those times like for you and your family.
This anonymous survey is now closed. We thank all who shared their time and experience in responding to the survey. Stay tuned for news of our completed submission to pCODR and INESSS.
If you have any questions or feedback about this topic or the survey itself, please email email@example.com